SCHEMBL5921916

SCHEMBL5921916

Nc1ccc(OCc2ccc(F)cc2Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.56
MAOB P27338 7/20 0.56
ADAMTS4 O75173 1/20 0.51
MMP2 P08253 1/20 0.51
MMP13 P45452 1/20 0.51
MMP14 P50281 1/20 0.51
ADAMTS5 Q9UNA0 1/20 0.51
NR4A2 P43354 1/20 0.46
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
INPPL1 O15357 2/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
MAOA P21397 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21340749 0.87 MAOB (0.56) RAB9AMAOBADAMTS4MMP2MMP13
SCHEMBL4339666 0.83 MAOB (0.61) RAB9AMAOBL3MBTL1GAAMAPT
SCHEMBL11562469 0.83 NR4A2 (0.63) NR4A2KMT2AMEN1ALDH1A1NPSR1
SCHEMBL4638512 0.83 MAOB (0.50) RAB9AMAOBADAMTS4MMP2MMP13
SCHEMBL17514658 0.81 RAB9A (0.53) RAB9AMAOBADAMTS4MMP2MMP13
SCHEMBL2983086 0.80 MAOB (0.50) RAB9AMAOBNR4A2INPPL1MAOA
SCHEMBL26128621 0.80 DHFR (0.44) RAB9AADAMTS4MMP2MMP13MMP14
SCHEMBL13220843 0.80 RAB9A (0.53) RAB9AMAOBADAMTS4MMP2MMP13
SCHEMBL29955554 0.80 RAB9A (0.53) RAB9AMAOBADAMTS4MMP2MMP13
SCHEMBL1283762 0.80 CACNA1C (0.59) RAB9AMAOBL3MBTL1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116730850-B Preparation method of 4- [ (2-chloro-4-fluorophenyl) methoxy ] -aniline 山东百启生物医药有限公司 2025-05-27 CN claimed
CN-116730850-A Preparation method of 4- [ (2-chloro-4-fluorophenyl) methoxy ] -aniline 山东百启生物医药有限公司 2023-09-12 CN claimed
EP-4676926-A1 BICYCLIC HETEROARYL COMPOUNDS FOR USE AS GPR35 MODULATORS ThirtyFiveBio Limited (GB) 2026-01-14 EP disclosed
US-20250214976-A1 GPR35 MODULATORS AND USES THEREOF CROSSIGNAL THERAPEUTICS, INC. 2025-07-03 US disclosed
CN-116730850-B Preparation method of 4- [ (2-chloro-4-fluorophenyl) methoxy ] -aniline 山东百启生物医药有限公司 2025-05-27 CN disclosed
CN-116730850-B Preparation method of 4- [ (2-chloro-4-fluorophenyl) methoxy ] -aniline 山东百启生物医药有限公司 2025-05-27 CN disclosed
CN-116730850-B Preparation method of 4- [ (2-chloro-4-fluorophenyl) methoxy ] -aniline 山东百启生物医药有限公司 2025-05-27 CN disclosed
EP-4504712-A1 GPR35 MODULATORS AND USES THEREOF Crossignal Therapeutics, Inc. (US) 2025-02-12 EP disclosed
CN-119137105-A GPR35 modulators and uses thereof 交信医药研发公司 2024-12-13 CN disclosed
WO-2024184650-A1 BICYCLIC HETEROARYL COMPOUNDS FOR USE AS GPR35 MODULATORS. ThirtyFiveBio Limited (GB) 2024-09-12 WO disclosed
WO-2023196538-A1 GPR35 MODULATORS AND USES THEREOF CROSSIGNAL THERAPEUTICS, INC. (US) 2023-10-12 WO disclosed
CN-116730850-A Preparation method of 4- [ (2-chloro-4-fluorophenyl) methoxy ] -aniline 山东百启生物医药有限公司 2023-09-12 CN disclosed
CN-116730850-A Preparation method of 4- [ (2-chloro-4-fluorophenyl) methoxy ] -aniline 山东百启生物医药有限公司 2023-09-12 CN disclosed
CN-116730850-A Preparation method of 4- [ (2-chloro-4-fluorophenyl) methoxy ] -aniline 山东百启生物医药有限公司 2023-09-12 CN disclosed
WO-2019141980-A1 AGRICULTURAL CHEMICALS GLOBACHEM NV (BE) 2019-07-25 WO disclosed
CN-1930121-A Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER PROD INC (US) 2007-03-14 CN disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD RAB9A 2063/4885MAOB 4396/4885ADAMTS4 4353/4885
US-20250214976-A1 GPR35 MODULATORS AND USES THEREOF GPR35, GPR34, GPR68 RAB9A 4154/4885MAOB 3706/4885ADAMTS4 4482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.